3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Head & Neck
1
Gynecologic
1
Conditions
Uterine Cervical Dysplasia
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
10
human papillomavirus vaccine, L1 type 16, 18
7
olaparib
4
niraparib
4
Human Papillomavirus Recombinant Vaccine nonavalent
4
Vaccines
3
Saline Solution
3
Papillomavirus Vaccines
3
Medroxyprogesterone Acetate
3
Carboplatin
3
Bevacizumab
3
pegylated granulocyte colony-stimulating factor
2
liposomal doxorubicin
2
fluciclovine F-18
2
apatinib
2
Sevoflurane
2
Propofol
2
Paclitaxel
2
Aspirin
2
semaglutide
1
pegfilgrastim
1
pazopanib
1
palbociclib
1
lenvatinib
1
halofantrine
1
ganirelix
1
gadofosveset trisodium
1
fosaprepitant
1
follicle stimulating hormone, human, with HCG C-terminal peptide
1
ferrous gluconate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Epinephrine
×
Gynecologic
×
Clear all
NCT02368054
2016-08-19
HSBAPCB
Helse Fonna
Phase 4
Completed
34 enrolled